NurExone Biologic Inc. (TSXV:NRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.7050
+0.0050 (0.71%)
May 1, 2025, 9:30 AM EDT

NurExone Biologic Statistics

Total Valuation

TSXV:NRX has a market cap or net worth of CAD 53.83 million. The enterprise value is 52.87 million.

Market Cap 53.83M
Enterprise Value 52.87M

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date May 27, 2025
Ex-Dividend Date n/a

Share Statistics

TSXV:NRX has 78.01 million shares outstanding. The number of shares has increased by 46.27% in one year.

Current Share Class n/a
Shares Outstanding 78.01M
Shares Change (YoY) +46.27%
Shares Change (QoQ) +11.89%
Owned by Insiders (%) 6.05%
Owned by Institutions (%) n/a
Float 73.29M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 21.24
P/TBV Ratio 21.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.29
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -6.64

Financial Position

The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.02.

Current Ratio 4.11
Quick Ratio 2.08
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.01
Interest Coverage -313.07

Financial Efficiency

Return on equity (ROE) is -517.23% and return on invested capital (ROIC) is -195.66%.

Return on Equity (ROE) -517.23%
Return on Assets (ROA) -135.79%
Return on Invested Capital (ROIC) -195.66%
Return on Capital Employed (ROCE) -245.18%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +17.50% in the last 52 weeks. The beta is 0.02, so TSXV:NRX's price volatility has been lower than the market average.

Beta (5Y) 0.02
52-Week Price Change +17.50%
50-Day Moving Average 0.65
200-Day Moving Average 0.64
Relative Strength Index (RSI) 54.03
Average Volume (20 Days) 12,540

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -7.21M
Pretax Income -7.26M
Net Income -7.26M
EBITDA -7.12M
EBIT -7.21M
Earnings Per Share (EPS) -0.11
Full Income Statement

Balance Sheet

The company has 1.01 million in cash and 47,482 in debt, giving a net cash position of 959,706 or 0.01 per share.

Cash & Cash Equivalents 1.01M
Total Debt 47,482
Net Cash 959,706
Net Cash Per Share 0.01
Equity (Book Value) 2.53M
Book Value Per Share 0.04
Working Capital 1.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.03 million and capital expenditures -933,807, giving a free cash flow of -7.97 million.

Operating Cash Flow -7.03M
Capital Expenditures -933,807
Free Cash Flow -7.97M
FCF Per Share -0.10
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TSXV:NRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -46.27%
Shareholder Yield -46.27%
Earnings Yield -13.48%
FCF Yield -14.80%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a